Dermapharm Holding SE (CHIX:DMPD) Short-Term Debt: €0 Mil (As of Mar. 2026)


CHIX:DMPD Dermapharm Holding SE CHIX:DMPD
80 GF Score
Price €46.18
GF Value €39.39
! 9 Warning Signs
View Full Analysis

What is Dermapharm Holding SE Short-Term Debt?

Dermapharm Holding SE CHIX:DMPD 80 Short-Term Debt is €0 Mil as of Mar. 2026. GuruFocus rates CHIX:DMPD with a GF Score™ of 80/100 and a GF Value™ of €39.39. The stock has 9 warning signs investors should review.

Dermapharm Holding SE's Short-Term Debt for the quarter that ended in Mar. 2026 was €0 Mil.

Dermapharm Holding SE's quarterly Short-Term Debt increased from Sep. 2025 (€0 Mil) to Dec. 2025 (€123 Mil) but then declined from Dec. 2025 (€123 Mil) to Mar. 2026 (€0 Mil).

Dermapharm Holding SE's annual Short-Term Debt declined from Dec. 2023 (€111 Mil) to Dec. 2024 (€85 Mil) but then increased from Dec. 2024 (€85 Mil) to Dec. 2025 (€123 Mil).

Dermapharm Holding SE Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Dermapharm Holding SE Short-Term Debt Related Terms

Dermapharm Holding SE Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Dermapharm Holding SE's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dermapharm Holding SE Short-Term Debt Chart

Dermapharm Holding SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.38 1.87 111.43 84.81 122.53

Dermapharm Holding SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 78.86 0.00 122.53 0.00
CHIX:DMPD
80GF Score
Dermapharm Holding SE CHIX:DMPD
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €0 Mil mean?
Dermapharm Holding SE (CHIX:DMPD) has a Short-Term Debt of €0 Mil as of Mar. 2026.
Is Dermapharm Holding SE's Short-Term Debt too high?
Dermapharm Holding SE's current Short-Term Debt is €0 Mil. Overall, Dermapharm Holding SE has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's Short-Term Debt compare to ZTS and UTHR?
Dermapharm Holding SE's Short-Term Debt of €0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Dermapharm Holding SE's current Short-Term Debt is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Dermapharm Holding SE (CHIX:DMPD) has a current Short-Term Debt of €0 Mil. The stock's GF Value™ is €39.39, compared to a current price of €46.18 — trading 17.2% above its estimated fair value. The current Short-Term Debt is €0 Mil. Dermapharm Holding SE's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Dermapharm Holding SE (CHIX:DMPD), the current Short-Term Debt is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dermapharm Holding SE (CHIX:DMPD) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of €46.18 is trading 17.2% above its estimated GF Value™ of €39.39.

Key valuation signals for CHIX:DMPD:

  • Short-Term Debt: €0 Mil
  • GF Value™: €39.39 vs. price of €46.18 (17.2% above fair value)
  • GF Score™: 80/100 with 9 warning signs

No single metric tells the full story. See the CHIX:DMPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dermapharm Holding SE Business Description

Other Exchanges DMPHF:USA0A5J:UKDMP:Germany
Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
80GF Score

Get the complete analysis for CHIX:DMPD

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.18
Price
€39.39
GF Value